Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AMLX is expected to report earnings to rise 19.83% to -50 cents per share on August 07

Amylyx Pharmaceuticals AMLX Stock Earnings Reports

Q2'25

Est.

$-0.50

Q1'25

Beat

by $0.20

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.37

Q2'24

Missed

by $0.34

The last earnings report on May 08 showed earnings per share of -41 cents, beating the estimate of -62 cents. With 989.96K shares outstanding, the current market capitalization sits at 410.94M.

View a ticker or compare two or three

Compare

AMLX